B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis

68Citations
Citations of this article
187Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The protective role of B cells and humoral immune responses in tuberculosis infection has been regarded as inferior to cellular immunity directed to the intracellular pathogen Mycobacterium tuberculosis. However, B-cell-mediated immune responses in tuberculosis have recently been revisited in the context of B-cell physiology and antigen presentation. We discuss in this review the diverse functions of B cells in tuberculosis, with a focus on their biological and clinical relevance to progression of active disease. We also present the peptide microarray platform as a promising strategy to discover unknown antigenic targets of M. tuberculosis that could contribute to the better understanding of epitope focus of the humoral immune system against M. tuberculosis.

Cite

CITATION STYLE

APA

Rao, M., Valentini, D., Poiret, T., Dodoo, E., Parida, S., Zumla, A., … Maeurer, M. (2015). B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis. Clinical Infectious Diseases, 61, S225–S234. https://doi.org/10.1093/cid/civ614

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free